These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. B cell antigens of the HLA system: a simple serotyping technique based on non-cytotoxic anti-beta2-microglobulin reagents. Bernoco D; Bernoco M; Ceppellini R; Poulik MD; Leeuwen A; Rood JJ Tissue Antigens; 1976 Oct; 8(4):253-60. PubMed ID: 62417 [TBL] [Abstract][Full Text] [Related]
5. Specific inhibition of T-cell-mediated cytolosis by alloantiserum against HLA-D-related (DR) antigens. Feighery CF; Stastny P Transplant Proc; 1979 Mar; 11(1):708-11. PubMed ID: 88098 [TBL] [Abstract][Full Text] [Related]
6. Appearance and evolution of anti-Da (B cell-specific) antibodies after planned immunizations. Belvedere M; Richiardi P; Savi M; Curtoni ES; Carbonara AO; Ceppellini R Tissue Antigens; 1978 Feb; 11(2):153-62. PubMed ID: 347631 [TBL] [Abstract][Full Text] [Related]
7. A screening program for anti-DR typing reagents. Vassalli P; Jeannet M; de Moerloose P; Chardonnens X Tissue Antigens; 1979 Jan; 13(1):77-80. PubMed ID: 311089 [TBL] [Abstract][Full Text] [Related]
8. Platelet absorption on the test tray (PATT): a rapid method for the screening of HLA class II antibodies using the two-colour fluorescence method. Cambon-Thomsen A; Sommer E; Demur C; Calot M; Ohayon E Tissue Antigens; 1985 Sep; 26(3):193-200. PubMed ID: 3901395 [TBL] [Abstract][Full Text] [Related]
10. Murine sera cytotoxicity toward human B cells and their effect on human mixed lymphocyte reactions. Verghese MW; Ward FE Transplantation; 1979 Aug; 28(2):107-10. PubMed ID: 158240 [TBL] [Abstract][Full Text] [Related]
11. Dilutions and specificity analysis of pretransplant sera. Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726 [TBL] [Abstract][Full Text] [Related]
12. Simplification of B-cell antisera of the Merrit system with platelets and lymphoblastoid cell lines. Naeim F; Gregg B; Gatti RA; Leibold W; Walford RL Transplant Proc; 1977 Mar; 9(1):439-44. PubMed ID: 68582 [TBL] [Abstract][Full Text] [Related]
13. [Differences in the capacity of HLA sera to react with T- and B-lymphocyte populations]. Zotikov EA; Tananov AT Biull Eksp Biol Med; 1976 Jun; 81(6):698-9. PubMed ID: 60152 [TBL] [Abstract][Full Text] [Related]
14. Alloantibodies to PHA-activated lymphocytes detect human Qa-like antigens. Gazit E; Gothelf Y; Gil R; Orgad S; Pitman TB; Watson AL; Yang SY; Yunis EJ J Immunol; 1984 Jan; 132(1):165-9. PubMed ID: 6606664 [TBL] [Abstract][Full Text] [Related]
15. Alloantisera with apparent HLA-A specificity reacting only against phytohemagglutinin-activated cells. Crepaldi T; Amoroso A; Curtoni ES; Richiardi P Ric Clin Lab; 1986; 16(3):449-56. PubMed ID: 2433726 [TBL] [Abstract][Full Text] [Related]
16. Use of turkey anti-human beta2-microglobulin antisera for identification of DR antibodies. Hunter SV; Benson JW; Bull RW; Poulik MD Transplant Proc; 1978 Dec; 10(4):853-5. PubMed ID: 83720 [No Abstract] [Full Text] [Related]
17. Detection of B-cell-specific alloantibodies in pregnancy sera in the lymphocytotoxicity and the indirect immunofluorescence techniques. Décary F; van Helden-Henningheim L; van Griethuysen D; Helmerhorst FM; van der Werf AJ; Engelfriet CP Tissue Antigens; 1979 Jul; 14(1):1-9. PubMed ID: 91215 [TBL] [Abstract][Full Text] [Related]
19. Alloantigens expressed on activated human T cells different from HLA-A, B, C, and DR antigens. Gerbase de Lima M; Wollman EE; Lepage V; Degos L; Dausset J Immunogenetics; 1981; 13(6):529-37. PubMed ID: 6974692 [TBL] [Abstract][Full Text] [Related]
20. Primate HLA antibodies are specifically mitogenic for human lymphocytes and act synergistically with beta2m antibodies. Ringdén O; Möller E; Sanderson AR Scand J Immunol; 1978 Apr; 7(4):337-43. PubMed ID: 77555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]